PanTHERA CryoSolutions

PanTHERA CryoSolutions develops patented ice recrystallization inhibitor (IRI) technology that enhances cryopreservation of cells, tissues, and organs, significantly improving post-thaw recovery and functionality. This technology reduces reliance on liquid nitrogen, enabling more cost-effective storage and transportation solutions for cell therapy applications.

Traction 5/10

Ottawa, Canada · HQ

Founded 201710500+ followers

Biotechnology

Updated 7 months ago

Funding

Raised to date

$4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Robert Ben

Co-Founder

Product

Features

PanTHERA CryoSolutions develops patented ice recrystallization inhibitor (IRI) technology that enhances cryopreservation of cells, tissues, and organs, significantly improving post-thaw recovery and functionality. This technology reduces reliance on liquid nitrogen, enabling more cost-effective storage and transportation solutions for cell therapy applications.